N@N

Europe losing cancer remedy tech race to US and China - study

The article from MSN discusses a study highlighting Europe's lag in the development of cancer treatment technologies compared to the United States and China. According to the study, Europe is falling behind in key areas such as immunotherapy, targeted therapies, and advanced diagnostics due to several factors including lower investment in research and development, regulatory hurdles, and a less integrated approach to innovation. The U.S. benefits from substantial private sector investment and a more streamlined regulatory environment, while China is rapidly advancing through significant government funding and a focus on biotechnological innovation. The study warns that if Europe does not increase its efforts in these critical areas, it risks becoming dependent on foreign technology for cancer treatments, potentially affecting patient outcomes and the continent's health sovereignty.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/environmental-science/europe-losing-cancer-remedy-tech-race-to-us-and-china-study/ar-AA1yknYA ]